BRIEF published on 05/15/2024 at 19:57, 6 months 5 days ago ALTAREIT Mixed General Meeting: Details on the Convocation and the Preparatory Documents Shareholders ALTAREIT General Assembly Summons Preparatory Document
BRIEF published on 05/07/2024 at 20:40, 6 months 13 days ago ALTAREIT announces the latest figures of its share capital Share Capital Voting Rights ALTAREIT Actions Threshold Crossing
BRIEF published on 05/07/2024 at 20:35, 6 months 13 days ago ALTAREIT publishes its own securities transactions report for April 2024 ALTAREIT Kepler Cheuvreux Actions Monthly Report Stock Transactions
BRIEF published on 04/05/2024 at 19:02, 7 months 15 days ago ALTAREIT: Monthly Activity on Own Securities in March 2024 Liquidity Contract ALTAREIT Kepler Cheuvreux March 2024 Corporate Actions
BRIEF published on 04/05/2024 at 18:59, 7 months 15 days ago ALTAREIT announces its total number of voting rights and shares for March 2024 Share Capital Voting Rights ALTAREIT Regulation Mandatory Notification
BRIEF published on 03/28/2024 at 19:05, 7 months 23 days ago PROVISION OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT BY ALTAREIT Financial Markets Authority ALTAREIT Financial Report Consolidated Accounts Universal Registration Document 2023
BRIEF published on 03/01/2024 at 17:43, 8 months 19 days ago ALTAREIT publishes details of its voting rights and share capital Share Capital Voting Rights ALTAREIT Regulation Threshold Crossing
BRIEF published on 03/01/2024 at 17:41, 8 months 19 days ago ALTAREIT reports its own share transactions for the month of February 2024 Liquidity Contract ALTAREIT Kepler Cheuvreux Paris Transactions On Own Shares
REGULATED PRESS RELEASE published on 02/27/2024 at 17:50, 8 months 22 days ago ALTAREIT : BUSINESS REVIEW ANNUAL RESULTS 2023
Published on 11/21/2024 at 13:30, 19 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 19 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 49 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 49 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 49 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 14 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 34 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 51 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 29 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
